Cancer Cell International
| 短名 | Cancer Cell Int |
| Journal Impact | 5.14 |
| 国际分区 | ONCOLOGY(Q1) |
| 期刊索引 | SCI Q1中科院 2 区 |
| ISSN | 1475-2867 |
| h-index | 80 |
| 国内分区 | 医学(2区)医学肿瘤学(3区) |
CANCER CELL INTERNATIONAL 发表关于癌细胞生物学各个方面的文章，主要来自但不限于使用细胞培养技术的工作。该杂志专注于新的癌症研究，报告来自对体外生长的细胞进行的生物学实验的数据，分为两个 -或三维系统，和/或体内（动物实验）。这些类型的实验为许多领域提供了重要数据，从细胞增殖和转化，到上皮-间质相互作用，再到细胞凋亡，以及宿主对肿瘤的免疫反应。CANCER CELL INTERNATIONAL 还考虑关注分子生物学中新技术或新途径的文章分析和可能影响患者护理的流行病学研究，以及报告将体外发现与临床联系起来的转化癌症研究的文章。因此，该杂志对报告肿瘤进展和治疗反应的新生物标志物及其对人类癌症的适用性的实验室和动物研究感兴趣。
期刊主页投稿网址| 涉及主题 | 生物遗传学医学化学生物化学内科学癌症研究癌症基因细胞凋亡免疫学病理细胞生物学细胞培养细胞细胞生长肿瘤科体外分子生物学下调和上调外科 |
| 出版信息 | 出版商: BioMed Central Ltd，出版周期: Irregular，期刊类型: journal |
| 基本数据 | 创刊年份: 2001，原创研究文献占比: 69.25%，自引率:0.00%， Gold OA占比: 99.57% |
| 平均审稿周期 | 网友分享经验：平均1月 |
| 平均录用比例 | 网友分享经验：约50% |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Correction: 4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis
2024-9-14
Glucose metabolism in glioma: an emerging sight with ncRNAs
2024-9-13
Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1
2024-9-13
Long-term zinc treatment alters the mechanical properties and metabolism of prostate cancer cells
2024-9-11
Sialylation-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in uterine corpus endometrial carcinoma
2024-9-11
Exosome-mediated transfer of lncRNA RP3-340B19.3 promotes the progression of breast cancer by sponging miR-4510/MORC4 axis
2024-9-10
Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors
2024-9-10
A novel risk stratification approach and molecular subgroup characterization based on coagulation related genes in colon adenocarcinoma
2024-9-9
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
2024-9-9
Hypoxia-induced BAP1 enhances erastin-induced ferroptosis in nasopharyngeal carcinoma by stabilizing H2A
2024-9-8
GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+ T cells
2024-9-8
E3 ubiquitin ligase BTBD3 inhibits tumorigenesis of colorectal cancer by regulating the TYRO3/Wnt/β-catenin signaling axis
2024-9-3
Recent updates on allogeneic CAR-T cells in hematological malignancies
2024-9-3
Exploring the promise of regulator of G Protein Signaling 20: insights into potential mechanisms and prospects across solid cancers and hematological malignancies
2024-9-3
Curcumin blunts epithelial-mesenchymal transition to alleviate invasion and metastasis of prostate cancer through the JARID1D demethylation
2024-9-1
Locoregional therapies combined with immune checkpoint inhibitors for liver metastases
2024-8-31
The sEVs miR-487a/Notch2/GATA3 axis promotes osteosarcoma lung metastasis by inducing macrophage polarization toward the M2-subtype
2024-8-31
Capsaicin combined with cisplatin inhibits TGF-β1-induced EMT and TSCC cells migration via the Claudin-1/PI3K/AKT/mTOR signaling pathway
2024-8-28
Characterization of the stem cell landscape and identification of a stemness-associated prognostic signature in bladder cancer
2024-8-24
Complicated role of ALKBH5 in gastrointestinal cancer: an updated review
2024-8-24
Prognostic and immunological implications of heterogeneous cell death patterns in prostate cancer
2024-8-24
Extracellular vesicle-bound VEGF in oral squamous cell carcinoma and its role in resistance to Bevacizumab Therapy
2024-8-23
Lipid metabolism associated crosstalk: the bidirectional interaction between cancer cells and immune/stromal cells within the tumor microenvironment for prognostic insight
2024-8-22
Correction: AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway
2024-8-17
Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer
2024-8-17
Sensitization of hepatocellular carcinoma cells to HDACi is regulated through hsa-miR-342-5p/CFL1
2024-8-16
Correction: ARAP1-AS1: A novel long non-coding RNA with a vital regulatory role in human cancer development
2024-8-16
Retraction Note: Transcription elongation factor A-like 7, regulated by miR-758-3p inhibits the progression of melanoma through decreasing the expression levels of c-Myc and AKT1
2024-8-14
Does rAj-Tspin, a novel peptide from A. japonicus, exert antihepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway?
2024-8-14
Establishment of patient-derived organoids and a characterization based drug discovery platform for treatment of gastric cancer
2024-8-14
Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1/JAK2/STAT3 pathway in gastric cancer
2024-8-12
Adipocytes promote metastasis of breast cancer by attenuating the FOXO1 effects and regulating copper homeostasis
2024-8-12
Enhancing mutation detection in multiple myeloma with an error-corrected ultra-sensitive NGS assay without plasma cell enrichment
2024-8-12
AFP-HSP90 mediated MYC/MET activation promotes tumor progression in hepatocellular carcinoma and gastric cancers
2024-8-12
TTI-101 targets STAT3/c-Myc signaling pathway to suppress cervical cancer progression: an integrated experimental and computational analysis
2024-8-12
Synergistic antitumor effect of liposomal-based formulations of olaparib and topotecan in primary epithelial ovarian cancer cells
2024-8-12
Identification of POU4F1 as a novel prognostic biomarker and therapeutic target in esophageal squamous cell carcinoma
2024-8-9
Retraction Note: Circular RNA hsa_circ_0000517 modulates hepatocellular carcinoma advancement via the miR-326/SMAD6 axis
2024-8-9
Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers
2024-8-8
Harnessing exosomes as cancer biomarkers in clinical oncology
2024-8-7
Enhanced anti-tumor effects by combination of tucatinib and radiation in HER2-overexpressing human cancer cell lines
2024-8-6
Multiple mechanisms contribute to acquired TRAIL resistance in multiple myeloma
2024-8-5
CircUBA2 promotes the cancer stem cell-like properties of gastric cancer through upregulating STC1 via sponging miR-144-5p
2024-8-5
Correction: MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome
2024-8-3
DDX19A promotes gastric cancer cell proliferation and migration by activating the PI3K/AKT pathway
2024-8-3
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
2024-8-3
MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression
2024-8-3
ARAP1-AS1: a novel long non-coding RNA with a vital regulatory role in human cancer development
2024-8-1
Oncogenic LINC00698 suppresses apoptosis of melanoma stem cells to promote tumorigenesis via LINC00698-miR-3132-TCF7/hnRNPM axis
2024-7-28
Unveiling heterogeneity and prognostic markers in ductal breast cancer through single-cell RNA-seq
2024-7-27
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远